Alkermes (ALKS) Liabilities from Discontinued Operations (2022 - 2023)
Alkermes (ALKS) reported Liabilities from Discontinued Operations of 4542000.0 for Q4 2023, down 66.46% year-over-year from 13542000.0 in Q4 2022, and down 66.46% quarter-over-quarter from 13542000.0 in Q4 2022.
Alkermes (ALKS) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends
Alkermes (ALKS) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 4542000.0 in Q4 2023.
- Liabilities from Discontinued Operations for Q4 2023 came in at 4542000.0, down 66.46% year-over-year; the trailing twelve-month figure through Dec 2023 was 4542000.0 (down 66.46% YoY), and the FY2023 annual result was 4542000.0, down 66.46% from the prior year.
- Liabilities from Discontinued Operations declined to 4542000.0 in Q4 2023 per ALKS's latest filing, from 13542000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 13542000.0 in Q4 2022 and troughed at 4542000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.54 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 13.54 Mn |
| Dec 31, 2022 | 13.54 Mn |